NCT02936102 A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. Status TERMINATED Phase PHASE1
NCT02934568 Ribociclib (LEE011) Rollover Study for Continued Access Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02927366 Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients Status TERMINATED Phase PHASE2
NCT02925104 A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors. Status COMPLETED Phase PHASE1
NCT02924727 Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI Status COMPLETED Phase PHASE3
NCT02913261 Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation Status COMPLETED Phase PHASE3
NCT02913105 Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH Status TERMINATED Phase PHASE2
NCT02911857 An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes Status COMPLETED Phase PHASE3
NCT02907281 Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis Status COMPLETED Phase N/A
NCT02900664 A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib) Status COMPLETED Phase PHASE1
NCT02900651 Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT02900378 randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure Status COMPLETED Phase PHASE3
NCT02896127 Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT02892344 Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma Status COMPLETED Phase PHASE3
NCT02892019 Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma Status COMPLETED Phase PHASE2
NCT02890069 A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat Status COMPLETED Phase PHASE1
NCT02888080 Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis Status COMPLETED Phase PHASE2
NCT02887183 Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes. Status COMPLETED Phase PHASE4
NCT02884206 Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction Status COMPLETED Phase PHASE3